GlassScriptPhysician profile
Samuel Porter Jacks
NPI 1184828030
$4,247.10
in general payments reported to CMS, 2019-2025
17 companies · $1,375 in 2025
The $1,375 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.03 · 2020: $41.51 · 2021: $264 · 2022: $432 · 2023: $1,879 · 2024: $202 · 2025: $1,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837 · Travel and Lodging: $1,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,837.47 |
| Travel and Lodging | $1,617.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,703.64 | 2023-2025 | Da Vinci Surgical System |
| Atricure, INC. | $698.07 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Ethicon US, LLC | $135.84 | 2022 | |
| Edwards Lifesciences Corporation | $129.95 | 2021 | |
| Zimmer Biomet Holdings, INC. | $115.68 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $79.10 | 2019-2021 | |
| Abiomed | $75.04 | 2019-2023 | Impella |
| Haemonetics Corporation | $65.55 | 2023 | Teg6s Hemostasis System |
| Artivion, INC. | $64.51 | 2023-2025 | Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical |
| Getinge USA Sales, LLC | $44.76 | 2022-2025 | Vasoview Hemopro 2 |
| Lsi Solutions INC | $31.11 | 2023 | Cor Knot |
| Davol INC. | $21.77 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.11 | 2019 | |
| Merck Sharp & Dohme LLC | $17.78 | 2021 | |
| Pfizer INC. | $16.37 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14.48 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Jacks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.